Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Artiva Biotherapeutics Inc (ARTV)

Artiva Biotherapeutics Inc (ARTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy
AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy Zacks Investment Research - Fri Dec 6, 10:42AM CST

Affimed N.V. AFMD announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to its pipeline candidate, acimtamig (AFM13).The regulatory body granted the RMAT designation...

AFMD : 1.1900 (+0.85%)
CSTL : 27.53 (+1.62%)
SPRO : 0.9551 (-4.30%)
ARTV : 11.11 (+11.10%)
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights GlobeNewswire - Tue Nov 12, 3:05PM CST

ARTV : 11.11 (+11.10%)
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference GlobeNewswire - Mon Nov 11, 3:05PM CST

ARTV : 11.11 (+11.10%)
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors GlobeNewswire - Tue Oct 22, 3:05PM CDT

ARTV : 11.11 (+11.10%)
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment Motley Fool - Thu Aug 29, 4:55AM CDT

Artiva's revolutionary cell therapies could be a patient lifeline and a goldmine for investors.

ARTV : 11.11 (+11.10%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot